RESPONSIBILITY. INNOVATION.
COLLABORATION

The University of Houston College of Pharmacy combines the opportunities and experiences of the Texas Medical Center’s world-class healthcare community with resources of the University of Houston, the state's premier urban teaching and research university, to offer its students the best possible education.

Degrees & Programs Apply Now

20 24
“Highest First-Time NAPLEX Pass Rate in Texas” National Association of Boards of Pharmacy

Research

UHCOP is home to award-winning teachers, researchers and mentors engaged in diverse investigations spanning basic, clinical and translational sciences in the areas of drug discovery and development, health outcomes and policy, and patient care initiatives.

6Research centers and institutes
$15.03MTotal research expenditures during FY 2024
7faculty members are among the top 2% of world's most-cited scientists

Explore Research

Apply for Admission

At the University of Houston, you can earn a degree, recognized both nationally and internationally, from an institution that has established itself as a leader in promoting academic advancement.

Pharm.D. Professional Degree Program Graduate Programs

Dual and Consecutive Degree Programs Residency & Fellowship

Estimated Tuition & Fees

Tuition and fees vary depending on your department, your residence status, your graduate level and the courses you're taking.

Academic Year 2026 Tuition Calculator

Latest News

Pharmacy Newsroom

September 30, 2026

Wang Elected Fellow of the American College of Cardiology

Elisabeth M. Wang, Pharm.D. (’16), BCCP, FACC, clinical associate professor, has been elected as a Fellow of the American College of Cardiology in recognition of her contributions to cardiovascular care, pharmacy education, scholarship and professional service.

September 28, 2026

New $3.1M NIH Grant for University of Houston to Study How ‘Spongy Heart’ Disease Develops — and Whether It Can Be Stopped

Mingfu Wu, professor of pharmacology, has received a $3.1 million grant from the National Institutes of Health to study how left ventricular noncompaction, commonly known as "spongy heart," disease develops in children. The serious condition can lead to heart failure, abnormal heart rhythms and other complications. Wu's study will investigate what causes the heart to develop abnormally and whether the biological processes involved could one day be interrupted.

September 23, 2026

Advancing Alzheimer’s Drug Repurposing Through AI and Brain Imaging

Supported by a $148,445 Alzheimer’s Association grant, UHCOP researcher Tiansheng Wang, Pharm.D., Ph.D., is using real-world health data, genetic information, brain imaging and artificial intelligence to identify existing medications that may warrant further study as potential treatments for Alzheimer’s disease and related dementias.